Australia markets closed

HOOKIPA Pharma Inc. (HOOK)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.6400+0.0019 (+0.30%)
At close: 04:00PM EDT
0.6701 +0.03 (+4.70%)
After hours: 07:25PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 63.33M
Enterprise value -23.34M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.29
Price/book (mrq)0.61
Enterprise value/revenue -4.40
Enterprise value/EBITDA 0.66

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-20.15%
S&P500 52-week change 324.96%
52-week high 31.1300
52-week low 30.4100
50-day moving average 30.8070
200-day moving average 30.6824

Share statistics

Avg vol (3-month) 3886.25k
Avg vol (10-day) 3473.87k
Shares outstanding 596.55M
Implied shares outstanding 698.95M
Float 850.91M
% held by insiders 119.58%
% held by institutions 141.55%
Shares short (15 May 2024) 4826.19k
Short ratio (15 May 2024) 40.69
Short % of float (15 May 2024) 41.07%
Short % of shares outstanding (15 May 2024) 40.84%
Shares short (prior month 15 Apr 2024) 4316.71k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -88.73%
Operating margin (ttm)33.81%

Management effectiveness

Return on assets (ttm)-20.19%
Return on equity (ttm)-50.55%

Income statement

Revenue (ttm)53.55M
Revenue per share (ttm)0.50
Quarterly revenue growth (yoy)1,052.40%
Gross profit (ttm)N/A
EBITDA -46.62M
Net income avi to common (ttm)-47.52M
Diluted EPS (ttm)-0.4800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)92.75M
Total cash per share (mrq)0.94
Total debt (mrq)6.08M
Total debt/equity (mrq)5.82%
Current ratio (mrq)4.50
Book value per share (mrq)1.06

Cash flow statement

Operating cash flow (ttm)-78.83M
Levered free cash flow (ttm)-53.89M